Cytokine adsorption in severely ill COVID-19 patients – rationale and clinical experience

Chairs: Prof. John Kellum, Pittsburgh, USA and Prof. Luciano Gattinoni, Göttingen, Germany

Speakers: Prof. Zhiyong Peng, Wuhan, China; Dr. Ivano Riva, Bergamo, Italy; Prof. Giorgio Berlot, Triest, Italy; Dr. Alexander Supady, Freiburg, Germany; Prof. Peter Hegyi, Pecs, Hungary

AGENDA

Introduction – Why hemoadsorption seems to be a useful treatment option
John Kellum

Safety and feasibility of CytoSorb therapy in COVID-19 patients – the Wuhan experience
Zhiyong Peng

It is more than just Cytokine removal – the Bergamo and Triest experience
Ivano Riva and Giorgio Berlot

Combination of ECMO and CytoSorb in COVID-19 patients – when and how should we do it
Alexander Supady

We have to collect data to create evidence! CYTOAID – an international multicenter observational trial
Peter Hegyi

Summary
Luciano Gattinoni

We look forward to welcoming you to our webinar! Your CytoSorbents Europe Team

Did you know...?

Find out more about our mail service offerings for different target groups and update your subscription preferences. Please do not hesitate to contact us, we are happy to provide you with any support needed!

Data privacy laws are in effect across Europe since May 25th 2018, so we are continuing to update our database. At the moment you currently enjoy regular electronic updates from us on the latest CytoSorbents news. 

• If you don’t want to miss out on any of these updates the good news is that you don’t have to do anything.
• If however, if you no longer wish to receive these updates that’s okay too, just simply unsubscribe by clicking here.

Kind regards,
Your CytoSorbents Europe Team